In a paper recently published in Nature Scientific Reports, IBM Research and scientists from several other medical institutions developed a new way to estimate the severity of a person’s Parkinson’s disease (PD) symptoms by remotely measuring and analyzing physical activity as motor impairment increased. Using data captured by wrist-worn accelerometers, we created statistical representations of […]
At IBM Research’s recent “The Path to More Flexible AI” virtual roundtable, a panel of MIT and IBM experts discussed some of the biggest obstacles they face in developing artificial intelligence that can perform optimally in real-world situations.
To assist in the fight against the COVID-19 pandemic, prominent research institutes led by Allen Institute for AI (AI2) released earlier this year the COVID-19 Open Research Dataset (CORD-19). Comprised of scientific articles related to COVID-19, Sars-Cov-2, and related coronaviruses, the dataset (which at the time of writing this contains more than 75,000 full text scientific papers) is […]
In a recent publication, IBM researchers describe a novel speaker diarization algorithm that can consider not only speaker information, but also identifying clues about individual recording environments that help differentiate between the speakers, resulting in improved diarization accuracy for our in-house, real test cases as well as public benchmark data.
In a new paper, researchers use the inspiration of the fruit fly olfactory network and a biologically plausible method for representation learning to propose a data-driven hashing algorithm for approximate similarity search.
The 58th Annual Meeting of the Association for Computational Linguistics (ACL 2020), the premiere annual conference on AI and language, takes place July 5-10. As is the case with most events currently, ACL will be virtual this year due to COVID-19. At IBM Research AI, we’re excited to share with you — wherever you might be in the world — all the work […]
Novel drug design is difficult, costly and time-consuming. On average, it takes $3 billion and 12 to 14 years for a new drug to reach market. One third of this overall cost and time is attributed to the drug discovery phase requiring the synthetization of thousands of molecules to develop a single pre-clinical lead candidate. […]
IBM Research plays a crucial role in advancing the foundational technology needed to support the artificial intelligence (AI) and hybrid cloud technologies driving IBM’s strategic business goals.